Market Cap
$40.53M
Shares Outstanding
11.7M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Aug 13, 2025
Round Lot
100
Locale
US
Day Open
$3.64
Day High
$3.72
Day Low
$3.41
Volume
10.9K
VWAP
$3.48
Prev Close
$3.59
Transactions
--
Acc. Volume
--
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Nasus Pharma Ltd. (NSRX) closed the 2026-09-16 session at $3.46, down 3.62% versus the previous close (-0.13). The stock opened at $3.64 and traded between $3.41 and $3.72 during that session. Session trading volume was 11K shares. The volume-weighted average price (VWAP) is $3.48.
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Nasus Pharma Ltd. has a market capitalization of $40.5 million. NSRX is listed on the XASE exchange. The company employs approximately 7 people. The recorded listing date is 2025-08-13.
On this page you can find market NSRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.